Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+ T Cells

Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection

(2018) Ashly Maughan et al.   Expert Opinion on Drug Metabolism & Toxicology

Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo

(2018) Carolina Garrido et al.   JOURNAL OF VIROLOGY

Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques

(2018) David Palesch et al.   JOURNAL OF VIROLOGY

Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses

(2018) Christopher W. Pohlmeyer et al.   PLoS One

Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir

(2017) James L. Riley et al.   JOURNAL OF INFECTIOUS DISEASES

Targeted Immune Interventions for an HIV-1 Cure

(2017) Matthieu Perreau et al.   TRENDS IN MOLECULAR MEDICINE

The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+ T cells

(2017) Abena K. Kwaa et al.   PLoS One

Progress Toward HIV Eradication: Case Reports, Current Efforts, and the Challenges Associated with Cure

(2016) Alyssa R. Martin et al.   Annual Review of Medicine

Targeting type I interferon–mediated activation restores immune function in chronic HIV infection

(2016) Anjie Zhen et al.   JOURNAL OF CLINICAL INVESTIGATION

Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function

(2016) Matthew Pace et al.   PLoS Pathogens

NK Cells in HIV Disease

(2016) Eileen Scully et al.   Current HIV/AIDS Reports

HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function

(2016) Carolina Garrido et al.   Frontiers in Immunology

The Effect of Latency Reversal Agents on Primary CD8 + T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication

(2016) Victoria E. Walker-Sperling et al.   EBioMedicine

Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D

(2015) Costin Tomescu et al.   AIDS

Understanding HIV Latency: The Road to an HIV Cure

(2015) Matthew S. Dahabieh et al.   Annual Review of Medicine

Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+T Cells to HIV-1-Specific CD8+T Cells

(2015) Victoria E. K. Walker-Sperling et al.   JOURNAL OF VIROLOGY

In VivoActivation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits AcuteIn VivoHIV-1 Infection in Humanized Mice

(2015) Kieran Seay et al.   JOURNAL OF VIROLOGY

Success and failure of the cellular immune response against HIV-1

(2015) Stephen A Migueles et al.   NATURE IMMUNOLOGY

B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers

(2015) Yoshinori Fukazawa et al.   NATURE MEDICINE

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

(2015) Ole S. Søgaard et al.   PLoS Pathogens

Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study

(2015) Julian H Elliott et al.   Lancet HIV

HIV-1 Expression Within Resting CD4+ T Cells After Multiple Doses of Vorinostat

(2014) N. M. Archin et al.   JOURNAL OF INFECTIOUS DISEASES

Comparative Analysis of the Capacity of Elite Suppressor CD4+ and CD8+ T Cells To Inhibit HIV-1 Replication in Monocyte-Derived Macrophages

(2014) V. E. K. Walker-Sperling et al.   JOURNAL OF VIROLOGY

HIV: The mixed blessing of interferon

(2014) Amalio Telenti   NATURE

Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression

(2014) Netanya G. Sandler et al.   NATURE

Potential Role for HIV-Specific CD38−/HLA-DR+ CD8+ T Cells in Viral Suppression and Cytotoxicity in HIV Controllers

(2014) Stéphane Hua et al.   PLoS One

Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy

(2014) Julian H. Elliott et al.   PLoS Pathogens

Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes

(2014) Richard Brad Jones et al.   PLoS Pathogens

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

(2014) Thomas A Rasmussen et al.   Lancet HIV

A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy

(2013) A. M. Spivak et al.   CLINICAL INFECTIOUS DISEASES

Interferon-α Is the Primary Plasma Type-I IFN in HIV-1 Infection and Correlates with Immune Activation and Disease Markers

(2013) Gareth A. D. Hardy et al.   PLoS One

An Interferon Paradox

(2013) P. M. Odorizzi et al.   SCIENCE

HIV Latency

(2013) R. F. Siliciano et al.   Cold Spring Harbor Perspectives in Medicine

Innate Immune Control of HIV

(2013) M. Carrington et al.   Cold Spring Harbor Perspectives in Medicine

Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers

(2012) Costin Tomescu et al.   AIDS

Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation

(2012) Liang Shan et al.   IMMUNITY

Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration

(2012) Livio Azzoni et al.   JOURNAL OF INFECTIOUS DISEASES

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

(2012) N. M. Archin et al.   NATURE

Interferon-Alpha Administration Enhances CD8+ T Cell Activation in HIV Infection

(2012) Maura Manion et al.   PLoS One

Type 1 Interferons and Antiviral CD8 T-Cell Responses

(2012) Raymond M. Welsh et al.   PLoS Pathogens

Receptor-Ligand Requirements for Increased NK Cell Polyfunctional Potential in Slow Progressors Infected with HIV-1 Coexpressing KIR3DL1*h/*y and HLA-B*57

(2011) P. Kamya et al.   JOURNAL OF VIROLOGY

Cytokine regulation of natural killer cell effector functions

(2010) Norberto W. Zwirner et al.   BIOFACTORS

HIV Protective KIR3DL1 and HLA-B Genotypes Influence NK Cell Function Following Stimulation with HLA-Devoid Cells

(2010) Salix Boulet et al.   JOURNAL OF IMMUNOLOGY